1 / 43

Prion Diseases

Prion Diseases. CMED 526/EPI 526 - May 6 th , 2009 Robert Harrington, DVM, PhD USDA – Agricultural Research Service UW – Dept. of Comparative Medicine rdhdvm@u.washington.edu. Transmissible Spongiform Encephalopathies~Prion Disease. NORMAL. ABNORMAL. PrP c. PrP d. -helix rich.

Renfred
Télécharger la présentation

Prion Diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Prion Diseases CMED 526/EPI 526 - May 6th, 2009 Robert Harrington, DVM, PhD USDA – Agricultural Research Service UW – Dept. of Comparative Medicine rdhdvm@u.washington.edu

  2. Transmissible Spongiform Encephalopathies~Prion Disease NORMAL ABNORMAL PrPc PrPd -helix rich -sheet rich Prusiner, et al.

  3. PrP Conversion PrPd PrPc Heterodimer

  4. TSE Pathogenesis • Transmission occurs by oral route • PrPd localizes to regional lymphoid tissue • Transient in some species • Migration to central nervous system • Retrograde along nerves • Blood-borne transport • Accumulation in brain with subsequent neurodegeneration

  5. Diagnosis • Postmortem • Microscopic pathology • Immunohistochemistry • ELISA, Immunoblotting • Bioassay • Antemortem • Same techniques as above applied to: • Brain biopsy • Tonsil, lymph node, third eyelid biopsy, or rectal • ? Blood test ?

  6. Histology Figure 3: Photomicrographs illustrating increased diameter and density of vacuoles in TME positive IC recipient (top row, a, b, c), as compared to CWD positive IC recipient, (middle row, d, e, f) and absence of lesions in CWD negative IC recipient (bottom, row, g, h, i). Left column = cerebral cortex, middle column = hippocampus, right column = thalamus. All sections stained with hematoxylin and eosin. Bar=100 µm.

  7. Immunohistochemistry

  8. Western blot

  9. Animal Prion Disease • Scrapie - sheep, goats • Chronic Wasting Disease (CWD) - deer, elk, moose • Bovine Spongiform Encephalopathy (BSE) - cattle • Transmissible mink encephalopathy (TME) - mink • Feline spongiform encephalopathy - large & domestic cats • Spongiform encephalopathy of captive ungulates - exotic hoof-stock in zoological parks

  10. Human Prion Disease • Sporadic • Creutzfeldt-Jakob disease (CJD) • Familial (genetic) • Familial CJD • Gerstman-Straussler-Scheinker Syndrome (GSS) • Fatal Familial Insomnia (FFI) • Acquired by transmission • Kuru • Iatrogenic CJD (neurosurgical instruments, dura mater grafts) • Variant CJD (vCJD)

  11. Human PrP Mutations Jackson, G S et al. Mol Pathol 2001;54:393-399

  12. Transmission Within Species vertical and horizontal in utero, fetal fluids, fetal membranes COMMON horizontal Oral (urine, feces, or blood?) Foodborne Direct only through bite wounds UNCOMMON Foodborne (MBM) No direct transmission from cow to cow Foodborne, blood, tissue transplant, HGH, instruments

  13. Species Barrier Concept • Transmission within a species may occur readily • Barrier between species limits transmission • Inefficient transmission • Extended incubation times • Low or non-existent rate of disease • Serial passage • Required to overcome species barrier • Progressive reduction in incubation time • Increased rate of disease

  14. Transmission Between Species SOURCE → → → → → → HOST ROUTE

  15. Recognition of BSE • Late 1985: Unusual neurologic disease in UK cattle • Insidious onset • Irritabilty, agression • Motor system impairment (ataxia) • Difficulty in rising (e.g. “downer cow”) • Decreased milk production • Wasting • Death • Predominantly dairy cattle • Feeding practices • Relative herd age • Neuropathology similar to Scrapie • Vacuolation, PrPd, astrocytosis, Scrapie associated fibrils

  16. Cause of BSE • Ruminant tissue in food chain • Meat and bone meal (MBM) • Scrapie • Sporadic BSE in cattle • Alternative theories • Human tissue? • Toxin? • Environmental? • Other?

  17. BSE Epidemic • ~180,000 cumulative cases in UK • Peaked at 37,000 cases per annum in 1992 • Recycling of ruminant tissue in food chain implicated • Progressive decline with introduction of feed bans

  18. (mammals) Transmissible Spongiform Encephalopathy as a Zoonotic Disease, Brown, P., et. al. ILSI, March 2003

  19. Spread of BSE Epidemic • 1990: Domestic BSE detected in Switzerland, imported cases in Portugal • 1999: 7 other EU countries with domestic BSE • Jan 2000 to Oct 2002: 11 additional EU countries • 2001: BSE detected in Japan • 2002: BSE detected in Israel • 2003: BSE in Canadian cow

  20. BSE in the United States • 30-40 million cattle slaughtered/year • 1997: ban on feeding US cattle meat-and-bone meal • 3 cases to date - RARE! • 2003: 6.5yo dairy cow imported from Canada • 2004: 12yo beef cow born and raised in Texas • 2006: 10yo beef cow in Alabama uncertain origin • Were there previously unrecognized cases?

  21. BSE in the United States • 2003: Additional measures post WA BSE case • “downer” cattle excluded from human consumption • Ban on SRM from animals >30 months of age from human consumption • Ban on mechanically-separated meat

  22. New variant CJD • Unusual form of neurologic disease in teenagers and young adults • Spongiform encephalopathy • Neuropathology not consistent with sporadic forms of CJD • Stimulus for US National Prion Disease Center

  23. Percent distribution of non-iatrogenic# UK vCJD and US CJD deaths, by age group, 1995-2005 + # Excludes blood transfusion-associated vCJD and pituitary hormone- or dural graft-associated CJD * UK vCJD deaths, including UK-related nonresident cases, 1995-2003 (Will, RG; personal communication, 2004) ** US CJD deaths, 1995- 2001.

  24. Western Blots Jackson, G S et al. Mol Pathol 2001;54:393-399

  25. BSE-vCJD Link • New variant disease that differs from classical CJD • Similarities to BSE • Geographically related to areas of BSE • Hypothesis: consumption of contaminated beef products • Epidemiologic curve • Animal challenge studies • Molecular biology

  26. BSE and vCJD Hilton, 2006. J of Pathology, 208:134

  27. Goldfarb, L. G. Microbes and Infection 4 (2002) 875-882

  28. Animal Challenge Studies • BSE → primates ≈ vCJD → primates • Similar lesions and biochemistry • Transgenic mice • BSE → humanized mice • vCJD → bovinized mice • Lesions, biochemistry of BSE ≈ vCJD regardless of mouse type • Both differ from sCJD

  29. Western Blots Jackson, G S et al. Mol Pathol 2001;54:393-399

  30. Continuing US Cattle Surveillance • USDA National Veterinary Services Laboratory • AAVLD certified labs, refer positives to NVSL • If 1 case per 1 million slaughter then 95% CI requires: • All slaughters = 2,995,731 • Suspect cattle = 40,000 (neuro signs, fallen, “downers”) • 45,803 samples in 2007 • Meets OIE “controlled risk” classification • National animal ID system

  31. Continuing US Human Surveillance • National Prion Disease Center • Established 1996 • Monitoring for unusual trends in mortality data • ↑ # of autopsies in US, ↑ # of referrals • CJD monitoring in CWD endemic areas

  32. CWD to Humans? • CJD flatline in endemic areas • Challenge studies indicate natural transmission is unlikely • Cattle • Mink • Humanized Tg mice

  33. CWD risk reduction? • Hunting • Avoid endemic areas • Test animals in effected areas • Consumption • Don’t eat brain, nerves, spleen, lymph nodes, or eyes • Avoid composite foods (sausage, head cheese)

  34. Conclusion • Prion diseases vary by species, distinct differences • TSE transmission usually limited to within a species • Only Scrapie and CWD are readily transmissible • Species barrier limits transmission between species

  35. Questions?

  36. Do you think this study supportsthe association of beef consumption as a primary risk factor for development of vCJD?

  37. Did the study authors take adequate measures to address the limitations to the study design?What other measures could they have considered?

  38. Are there other ways that the question of risk factors for vCJD may be addressed?

More Related